UBS Group’s Chemomab Therapeutics CMMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461 | Sell |
|
|||||
|
2025
Q1 | $962 | Buy |
|
|||||
|
2024
Q4 | $878 | Sell |
|
|||||
|
2024
Q3 | $3.59K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $126 | Buy |
|
|||||
|
2023
Q2 | $16 | Sell |
|
|||||
|
2023
Q1 | $653 | Sell |
|
|||||
|
2022
Q4 | $14.8K | Sell |
|
|||||
|
2022
Q3 | $12K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4K | Sell |
|
|||||
|
2021
Q4 | $13K | Buy |
|
|||||
|
2021
Q3 | $19K | Buy |
|
|||||
|
2021
Q2 | $3K | Sell |
|
|||||
|
2021
Q1 | $24K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $6K | Sell |
|
|||||
|
2019
Q1 | $19K | Buy |
|